EU to assess risks of 'bute' in horse meat

by Meat&Poultry Staff
Share This:

BELGIUM – Two European Union agencies will conduct a joint assessment of the risks to human health from phenylbutazone, or "bute", in horse meat.

The European Commission asked the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) to conduct the assessment after horse meat was found in a variety of products throughout the EU, and the discovery of phenylbutazone in "a small number of horse carcasses" intended for human consumption. EFSA and EMA have a deadline of April 15 to advise the Commission on any potential health risks to consumers from the presences of phenylbutazone residues in horse meat.

"In this regard, the agencies will consider both the risk posed from consumption of horsemeat itself as well as that arising from other products illegally contaminated with horse meat," according to an EFSA news release. "The agencies have been asked to advise, where appropriate, if additional control options are needed to minimize any risks identified."

Phenylbutazone, an anti-inflammatory drug, can be used to treat non-food producing animals, such as dogs and sport horses. But it cannot be used to treat food animals in EU member states. EFSA stated that any residues found in food containing animal meat resulted from the illegal use of carcasses of treated horses.

Comment on this Article
We welcome your thoughtful comments. Please comply with our Community rules.

 

 


The views expressed in the comments section of Meat and Poultry News do not reflect those of Meat and Poultry News or its parent company, Sosland Publishing Co., Kansas City, Mo. Concern regarding a specific comment may be registered with the Editor by clicking the Report Abuse link.